Sorted By:

Relevance


Senior Director – Federal Advocacy

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org/careers/senior-director-federal-advocacy

Cancers: Decline in Death Rates

Chartpack  |  From Our Network

Cancer death rates have declined 23% since their peak in 1991 and approximately 83% of survival gains can be attributed to new medicines and treatments....
http://chartpack.phrma.org/2016-perspective/chapter-1/cancers-decline-in-death-rates

More Than 240 Innovative Medicines in Development For Leukemia, Lymphoma and Other Blood Cancers

PhRMA  |  Press Release

Also, our evolving understanding of the genetic and molecular make-up of cells has helped researchers develop better treatments for blood cancers, including therapies that allow blood cancer patients to recover more quickly after treatment.
https://www.phrma.org/press-release/more-than-240-innovative-medicines-in-development-for-leukemia-lymphoma-and-other-blood-cancers

PhRMA & LLS: More than 240 Medicines in Development for Blood Cancers

PhRMA  |  Blog Post

Additional Resources Download the 2015 Report: 240+ Medicines in Development for Blood Cancers 2014 Report: 771 Medicines in Development for Cancer From Hope to Cures: Cancer And the really encouraging news for patients?
http://catalyst.phrma.org/phrma-lls-more-than-240-medicines-in-development-for-blood-cancers

Solutions Architect - IT

PhRMA  |  PhRMA Career

We are committed to supporting our staff and strive to create programs that help our team manage the challenges of balancing a fast paced career with personal goals.
https://www.phrma.org/careers/solutions-architect-it

Director – Policy & Research

PhRMA  |  PhRMA Career

Please check our careers page for more opportunities.
https://www.phrma.org/careers/director-policy-and-research

Researchers Have Made Great Progress Identifying Genes that—when Mutated—Drive Many Cancers, but Challenges Remain

Chartpack  |  From Our Network

Identifying genetic mutations has led to tremendous advances against many cancers, but the complexity of each disease presents great challenges for researchers, as they explore still yet unknown alterations and work to link them to personalized medicine treatment options.  
http://chartpack.phrma.org/personal-medicines-in-development-chartpack/an-evolving-pipeline/researchers-have-made-great-progress-identifying-genes-that-when-mutated-drive-many-cancers-but-challenges-remain

Director of Development – Healthcare Ready

PhRMA  |  PhRMA Career

We are committed to supporting our staff and strive to create programs that help our team manage the challenges of balancing a fast paced career with personal goals.
https://www.phrma.org/careers/director-of-development-healthcare-ready

Senior Director - Public Affairs Research

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org/careers/senior-director-public-affairs-research

Director - Communications

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org/careers/director-communications

Director – State Advocacy

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org/careers/director-state-advocacy

The List Of Cancers That Can Be Treated By Immunotherapy Keeps Growing

From Hope To Cures  |  From Our Network

In addition to melanoma, the infusion drugs already have been approved for use against lung and kidney cancers.
http://www.fromhopetocures.org/the-list-of-cancers-that-can-be-treated-by-immunotherapy-keeps-growing

New PhRMA Report: 836 medicines and vaccines in development to treat cancers

PhRMA  |  Blog Post

According to a new PhRMA report released today, America’s biopharmaceutical research companies are currently developing 836 medicines and vaccines to treat a broad range of cancers.
http://catalyst.phrma.org/new-phrma-report-836-medicines-and-vaccines-in-development-to-treat-cancers

Cells - Leukemia and Lymphoma

PhRMA  |  Video

America’s biopharmaceutical companies are working to harness the power of the body’s immune system to fight infectious diseases and cancers like leukemia and lymphoma. 
https://www.phrma.org

Advances in Personalized Medicine Improve Outlook for Patients with Blood Cancers

Chartpack  |  From Our Network

There are nearly 250 medicines are in development for blood cancers and 5 year survival rates have grown to 70% through a greater understanding of the molecular basis of disease. 
http://chartpack.phrma.org/personal-medicines-in-development-chartpack/benefiting-patients-and-the-health-care-system/advances-in-personalized-medicine-improve-outlook-for-patients-with-blood-cancers

Senior Director – Science and Regulatory Advocacy (Biologics and Biosimilars Advocacy)

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org/careers/senior-director-science-and-regulatory-advocacy-biologics-and-biosimilars-advocacy1

Highlighting advances in science during Breast Cancer Awareness Month

PhRMA  |  Blog Post

The cancer death rate has fallen 22 percent since its peak in 1991, and the chances that a cancer patient will live 5 years or more has increased by 39 percent across all cancers.
http://catalyst.phrma.org/making-strides-against-breast-and-other-cancers

Medicines have significantly increased chances of cancer survival around the globe

PhRMA  |  Blog Post

Personalized medicines such as immunotherapy are transforming cancer care in ways never before seen, using patients’ immune systems to fight or eliminate cancers.
http://catalyst.phrma.org/medicines-have-significantly-increased-chances-of-cancer-survival-around-the-globe

Medicines in Development for Leukemia & Lymphoma 2015 Report

PhRMA  |  Report

Major types of blood cancers include leukemia, lymphoma and myeloma.
https://www.phrma.org/report/medicines-in-development-for-leukemia-and-lymphoma-2015-report

Significant progress fighting cancer: Death rate has dropped 25 percent

PhRMA  |  Blog Post

In the last decade, we’ve seen a number of scientific advances transform the landscape of many cancers.
http://catalyst.phrma.org/significant-progress-fighting-cancer-death-rate-has-dropped-25

A critical opportunity to prevent prescription drug abuse

PhRMA  |  Blog Post

As someone who has spent the bulk of my career focused on issues related to substance abuse, including more than 10 years with PhRMA and prior to that almost 8 years in the White House Drug Policy Office, I am heartened to see the FDA commit to helping solving this problem.
http://catalyst.phrma.org/a-critical-opportunity-to-prevent-prescription-drug-abuse

What is Personalized Medicine?

Chartpack  |  From Our Network

Personalized medicine is an emerging field of medicine that uses diagnostic tools to identify specific biological markers to help assess which medical treatments and procedures will be best for each patient.
http://chartpack.phrma.org/personal-medicines-in-development-chartpack/a-new-treatment-paradigm/what-is-personalized-medicine

Fighting Leukemia and Lymphoma

From Hope To Cures  |  From Our Network

More Than 240 Medicines in Development for Leukemia, Lymphoma and Other Blood Cancers
http://www.fromhopetocures.org/fighting-leukemia-and-lymphoma

Honoring veterans serving in the biopharmaceutical industry

PhRMA  |  Blog Post

Caskey noted that he’s encouraged by the veteran hiring initiatives across the biopharmaceutical industry, including Merck, Pfizer and Eli Lilly which represent just some of the many companies that have programs in place aimed at hiring veterans.
http://catalyst.phrma.org/honoring-veterans-serving-in-the-biopharmaceutical-industry

Medicare Monday: A discussion on affordability and access to medicines

PhRMA  |  Blog Post

It’s why former President Jimmy Carter is now cancer-free, and why the broader cancer death rate in the United States has fallen by 23 percent since its peak and the five-year survival rate has increased 41 percent across all cancers, according to the American Cancer Society.
http://catalyst.phrma.org/medicare-monday-a-discussion-on-affordability-and-access-to-medicines

You have reviewed the first 50 results out of 263. Each page contains 25 results. You're on page 2.

prev 1 2 3 4 5 6 next